Valuation (45%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.76 | 6.89 |
PEG Ratio (TTM) | 0.07 | -0.57 |
P/S Ratio (TTM) | 0.27 | 5.34 |
P/B Ratio (TTM) | 0.79 | 17.70 |
P/FCF Ratio (TTM) | 23.39 | 17.43 |
Price to 5YR AVG Earnings Ratio | N/A | 25.65 |
Price to 5YR AVG FCF Ratio | N/A | 14.34 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -15.56% | 5.55% |
ROE (TTM) | -25.93% | 54.04% |
Net Profit Margin (TTM) | -9.07% | -139.23% |
ROIC 5YR AVG | N/A | 7.95% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -361.48% | 30.58% | N/A |
Revenue | -0.71% | 0.43% | N/A |
Net Income | -344.83% | 31.59% | N/A |
Cash Flow | 34.13% | -389.15% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.18 | 1.62 |
Quick Ratio (TTM) | 1.42 | 1.36 |
D/E Ratio (TTM) | 0.49 | 1.51 |
Interest Coverage (TTM) | -4.51 | 8.40 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.80 | 5.62 |
LTL to 5YR AVG FCF | N/A | 1.59 |
Shares Outstanding Growth 5YR AVG | N/A | -0.13% |